Matthew Ros Insider Trading
Get free email notifications about insider trading for Matthew Ros.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Ros. Matthew Ros is a Chief Operating Officer in Epizyme, Inc. ($EPZM) and a See Remarks in Epizyme, Inc. ($EPZM) and a Director in Unum Therapeutics Inc. ($UMRX).
Address: C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE 02139 MA
Companies in which Matthew Ros is an Insider
Cogent Biosciences, Inc.
Trading Symbol: COGTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Ros: Director
Holdings: 0 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Epizyme, Inc.
Trading Symbol: EPZMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Ros: See Remarks, Chief Operating Officer
Holdings: 84,082 shares
Current Value: $1,013,188
Latest Transaction: Feb 02 2021
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew Ros
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | COGT | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 9.08 | 2,068 | 18,777 | 2,068 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
Feb 02 2021 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Option Exercise | A | 11.02 | 134,178 | 1,478,642 | 134,178 | |
Feb 02 2021 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Grant | A | 0.00 | 28,125 | 0 | 84,082 | 56 K to 84.1 K (+50.26 %) |
Jan 27 2021 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Sell | S | 11.41 | 2,872 | 32,770 | 55,957 | 58.8 K to 56 K (-4.88 %) |
Jan 06 2021 | UMRX | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 7.62 | 1,641 | 12,503 | 1,641 | |
Oct 02 2020 | UMRX | Unum Therapeutics ... | Ros Matthew | Director | Option Exercise | A | 2.26 | 9,247 | 20,898 | 9,247 |